Home > Insider Trading > Filing (0001209191-16-126260)

Filing Details

Accession Number:: 0001209191-16-126260
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2016-06-07 16:31:57
Reporting Period:: 2016-06-07

Filing Date:: 2016-06-07
Accepted Time:: 2016-06-07 16:31:57
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1539029	Clearside Biomedical Inc.	CLSD	Pharmaceutical Preparations (2834)	452437375

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1592380	Clay Thorp	C/O Clearside Biomedical, Inc. 1220 Old Alpharetta Road, Suite 300 Alpharetta GA 30005		Yes	No	Yes	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2016-06-07	3,321,785	$0.00	3,433,833	No	4	C	Indirect	See Footnotes
Common Stock	Acquisiton	2016-06-07	43,410	$0.02	3,477,243	No	4	X	Indirect	See Footnotes
Common Stock	Disposition	2016-06-07	138	$7.00	3,477,105	No	4	S	Indirect	See Footnotes
Common Stock	Acquisiton	2016-06-07	785,714	$7.00	4,262,819	No	4	P	Indirect	See Footnotes

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	C	Indirect	See Footnotes
No	4	X	Indirect	See Footnotes
No	4	S	Indirect	See Footnotes
No	4	P	Indirect	See Footnotes

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Series A Preferred Stock	Disposition	2016-06-07	4,071,815	$0.00	1,850,823	$0.00
Common Stock	Series A-1 Preferred Stock	Disposition	2016-06-07	1,654,531	$0.00	752,058	$0.00
Common Stock	Series B Preferred Stock	Disposition	2016-06-07	865,881	$0.00	393,581	$0.00
Common Stock	Series C Preferred Stock	Disposition	2016-06-07	675,795	$0.00	325,323	$0.00
Common Stock	Warrant to Purchase Common Stock (right to buy)	Disposition	2016-06-07	19,900	$0.00	19,900	$0.02
Common Stock	Warrant to Purchase Common Stock (right to buy)	Disposition	2016-06-07	1,805	$0.00	1,805	$0.02
Common Stock	Warrant to Purchase Common Stock (right to buy)	Disposition	2016-06-07	21,705	$0.00	21,705	$0.02

Exercise Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
	No	4	C	Indirect
	No	4	C	Indirect
	No	4	C	Indirect
	No	4	C	Indirect
2014-04-28	No	4	X	Indirect
2014-04-28	No	4	X	Indirect
2014-04-28	No	4	X	Indirect

Footnotes

The total represents shares received upon conversion of shares of Series A Preferred Stock, Series A-1 Preferred Stock, Series B PreferredStock and Series C Preferred Stock.
Effective immediately prior to the closing of the Issuer's initial public offering of its common stock, each share of Series A Preferred Stock,Series A-1 Preferred Stock and Series B Preferred Stock automatically converted into 0.454545 shares of the Issuer's common stock, and eachshare of Series C Preferred Stock automatically converted into 0.4814 shares of the Issuer's common stock. The Preferred Stock had noexpiration date.
The reporting person is one of the general partners of: (i) Hatteras Venture Advisors III, LLC, the general partner of Hatteras Venture Partners III, LP ("HVP III") and Hatteras Venture Affiliates III, LP ("HVA III"); (ii) Hatteras Venture Advisors IV SBIC, LLC, the general partner of Hatteras Venture Partners IV SBIC, LP ("HVP IV SBIC"); and (iii) Hatteras Venture Advisors IV, LLC, the general partner of Hatteras Venture Partners IV, LP ("HVP IV") and Hatteras NC Fund, LP ("Hatteras NC"). HVP III, HVA III, HVP IV SBIC, HVP IV and Hatteras NC are the record holders of the securities, and the reporting person may be deemed to share voting and dispositive power over the securities held by HVP III, HVA III, HVP IV SBIC, HVP IV and Hatteras NC.
The reporting person disclaims beneficial ownership of these securities and this report is not an admission that the reporting person is a beneficial owner of such securities for purposes of Section 16 or for any other purpose, except to the extent of his pecuniary interest therein.
On June 7, 2016, HVP III, HVA III and HVP IV SBIC exercised warrants to purchase an aggregate of 43,410 shares of Issuer's common stock for $0.022 per share.HVP III, HVA III and HVP IV SBIC paid the exercise price on a cashless basis, resulting in the Issuer's withholding of an aggregate of 138 of the warrant shares to pay the exercise price and issuing to the reporting person the remaining 43,272 shares.
This warrant would have expired upon the closing of the Issuer's initial public offering.
This warrant was held directly by HVP III.
This warrant was held directly by HVA III.
This warrant was held directly by HVP IV SBIC.